Orrick represented Barclays as underwriter in the public offering by selling stockholders of 3,000,000 shares of Rapid7, Inc. (“Rapid7”) common stock. The underwriter purchased the shares…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
